# Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants

> **NCT06133478** · PHASE1 · COMPLETED · sponsor: **Nuvamid SA** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** NUV001 active cohort 1
- **DRUG:** NUV001 active cohort 2
- **DRUG:** NUV001 active cohort 3
- **DRUG:** NUV001 active cohort 4
- **DRUG:** NUV001 placebo cohort 1
- **DRUG:** NUV001 placebo cohort 2
- **DRUG:** NUV001 placebo cohort 3
- **DRUG:** NUV001 placebo cohort 4

## Key facts

- **NCT ID:** NCT06133478
- **Lead sponsor:** Nuvamid SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-09
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-04-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06133478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06133478, "Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06133478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*